New study tracks Dupilumab's Real-World impact on swallowing and quality of life
NCT ID NCT06695897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 150 adults with eosinophilic esophagitis (EoE) who are starting dupilumab as part of their normal care. Researchers will collect information on medical history, symptoms, and quality of life over two years to see how well the treatment works in real-world settings. The goal is to better understand long-term safety and effectiveness outside of a controlled clinical trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Investigational Site Number: 0000001
RECRUITINGDachau, Bavaria, 85221, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Swallowable sponge could replace endoscopy for esophagitis monitoring
- Blood tests may replace scopes for EoE diagnosis
- Massive new registry aims to crack the code on mysterious gut disorders
- 300 kids with EoE enrolled in landmark database study
- Could ditching milk soothe a painful esophagus? new trial tests Diet-Only approach
- Can cutting four foods ease Kids' esophagus inflammation?